Fetuin-A as a risk factor for mortality in hemodialysis patients

Wiener Klinische Wochenschrift

Volumn 122, Issue SUPPL. 2, 2010, Pages 63-67

  Balon, Breda Pečovnik ^a,b   Knehtl, Maša ^a   Bevc, Sebastjan ^a   Jakopin, Eva ^a   Gorenjak, Maksimiljan ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Calcium; Fetuin A; Hemodialysis; Mortality; Phosphorus; Vascular calcification

Indexed keywords

ACUTE PHASE PROTEIN; ALKALINE PHOSPHATASE; BICARBONATE; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; FETUIN A; HOMOCYSTEINE; PARATHYROID HORMONE; PHOSPHORUS; SERUM ALBUMIN; TRIACYLGLYCEROL; AHSG PROTEIN, HUMAN; PLASMA PROTEIN;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; KAPLAN MEIER METHOD; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; RISK FACTOR; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CAUSE OF DEATH; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; REFERENCE VALUE; RENAL REPLACEMENT THERAPY; SLOVENIA; STATISTICS;

AGED; ALKALINE PHOSPHATASE; BLOOD PROTEINS; CALCIUM; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; PROSPECTIVE STUDIES; REFERENCE VALUES; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN; SLOVENIA; STATISTICS AS TOPIC; TRIGLYCERIDES; ALPHA-2-HS-GLYCOPROTEIN; KAPLAN-MEIER ESTIMATE;

EID: 77955542942     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-010-1348-7     Document Type: Article

References (24)

1. Unger F (2008) Health is Wealth - toward a European lead market in health care. Acta Medico-Biotechnica 1: 11-18
2. Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, et al (2005) Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 20: 1676-1685
3. La Clair R, O'Neal K, Ofner S, Sosa MJ, Labarrere CA, et al (2008) Precision of biomarkers to define chronic inflammation in CKD. Am J Nephrol 28: 808-812
4. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740
5. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942
6. Ketteler M (2005) Fetuin-A and extraosseous calcification in uremia. Curr Opin Nephrol Hypertens 14: 337-342
7. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Boem R, et al (2003) Association of low fetuin- A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361: 827-833
8. Cozzolino M, Mazzaferro S, Pugliese F, Brancaccio D (2008) Vascular calcification and uremia: what do we know? Am J Nephrol 28: 339-346
9. Pupim LB, Himmelfarb J, McMonagle E, Shyr Y, Ikizler TA (2004) Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. Kidney Int 65: 2371-2379
10. Honda H, Quereshi AR, Heimbuerger O, Barany P, Wang K, Pecoits-Filho R, et al (2006) Serum albumin, C-reactive protein, interleukin-6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47: 139-148
11. Stenvinkel P, Wang K, Quereshi AR, Axelsson J, Pecoits-Filho R, Gao P, et al (2005) Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 67: 2383-2392
12. El-Abbadi M, Giachelli CM (2005) Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench. Curr Opin Nephrol Hypertens 14: 519-524
13. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, Takasu J, et al (2005) Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 67: 1070-1077
14. Moe MS, Reslerova M, Ketteler M, O'Neill K, Duan D, Koczman J (2005) Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 67: 2295-2304
15. Cooper BA, Penne EL, Bartlett LH, Pollock CA (2004) Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 43: 61-66
16. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, et al (2005) Multifunctional roles for serum protein fetuin-A in inhibition of vascular smooth muscle cell calcification. J Am Soc Nephrol 16: 2920-2930
17. Kalpakian MA, Mehrotra R (2007) Vascular calcification and disordered mineral metabolism in dialysis patients. Semin Dial 20: 139-143
18. Mehrotra R (2007) Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease. Kidney Int 72: 137-140
19. Hermans MMH, Brandenburg V, Ketteler M, Kooman JP, Van der Sande FM, Boeschoten EW (2007) Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 72: 202-207
20. Papagianni A (2008) Serum fetuin-A levels, aortic calcification and mortality in chronic haemodialysis patients. NDT Plus 1: 341
21. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO4, Ca × PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12: 2131-2138
22. Marco MP, Craver L, Betriu A, Belart M, Fibla J, Fernandez E (2003) Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population. Kidney Int 63[Suppl 85]: 111-114
23. Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT (2005) The kidney disease outcomes quality initiative (K/DOQI) guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis 46: 925-932
24. Block GA, Klassen PS, Lazarus MJ, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218